Abbott Laboratories: Russia Operations Status & Business Impact
Also known as: Abbot Labs; Abbott Labs
LeaveRussia detail: Pausing Investments
Abbott Laboratories is an American multinational medical devices and health care company. It sells medical devices, diagnostics, branded generic medicines and nutritional products.
Business in Russia
Pharmaceutical production. There have been problems with the import of products for the treatment of diabetes.
Decision trail
Decision date 29/04/2022 · Reference ↗
The company suspends non-essential business activity in the country, including all new investments, business development and advertising. So far, the only product (treatment of diabetes) left on the Russian market is the American Abbott.
Local stats (LeaveRussia)
Status history since 2022
- 03/08/2026 — suspended · Imported from KSE LeaveRussia
Exposure profile
Get alerts if this company's Russia status changes
7-day Pro trial includes watchlists for companies you track. No credit card. Full exposure maps are on Professional after the trial.
Start 7-day Pro trialGeopolitical context and sanctions impact
Abbott Laboratories is a Pharma & Healthcare company based in USA. Current Russia status in our dataset is suspended: paused activity does not always mean a clean legal exit — licences, local entities and unpaid obligations can remain. Eastern Europe Impact translates those facts into business consequences — sanctions screening, supply-chain exposure and reconstruction-side opportunity — with transparent confidence labels rather than speculation.
Risk assessment and how to use this profile
Start with the status badge and decision trail, then check possible sanctions matches and recent events mentioning Abbott Laboratories. A 7-day Pro trial adds watchlists so you are notified if Russia status, designations or linked events change. Full exposure maps (energy, transport, commodities) are on Professional. This page is risk information, not legal or investment advice.
Questions about Abbott Laboratories
What kind of data does Eastern Europe Impact provide on Abbott Laboratories?
- Eastern Europe Impact publishes verified intelligence on Abbott Laboratories's Russia status: current operating posture, sources (including the KSE LeaveRussia project), status history since 2022, sanctions-list matches, and linked events. Each profile is risk information for compliance and due diligence — not legal advice.
How can Eastern Europe Impact data on Abbott Laboratories help my business?
- Use the Abbott Laboratories profile to check counterparties, suppliers and customers for Russia exposure, sanctions proximity and recent events before you contract, ship or invest. Watchlists alert you if the status or designations change.
How do we verify the information on Abbott Laboratories?
- We compile public reporting, company statements and the KSE LeaveRussia dataset, then label uncertainty. Status is not a legal determination — verify against primary filings and counsel before acting. Corrections go to corrections@easterneuropeimpact.com.
How much does Eastern Europe Impact cost?
- The company checker is free. A 7-day Pro trial (no credit card) unlocks live Daily Impact Briefs, full event profiles and watchlists. After the trial, Individual is €19/month; Professional and Business add exposure maps, sanctions entity pages and API access. See /pricing.